Taiho Oncology, Inc.
David Putteet has extensive work experience in the field of pharmacovigilance and regulatory affairs. David most recently worked at Taiho Oncology, Inc. as the Sr. Director of PV Data Management and Case Processing. Prior to that, they held the position of Director of PV Data Management and Case Processing at the same company. David also worked as the Director of IT Safety Systems at ICON plc, Director of Safety Systems at Incyte, Director of Clinical Systems at inVentiv Health Clinical, and Director of Safety Systems at ICON plc (formerly Akos, Limited). Earlier in their career, they worked as a Senior Manager of Pharmacovigilance and Regulatory Affairs Systems at Regeneron Pharmaceuticals and as an Implementation Project Manager at Aris Global.
David Putteet attended the University of South Alabama from 1998 to 2004 and obtained a Bachelor's degree in Finance, General. It is unclear whether they pursued any further education or obtained an additional degree in the same field.
This person is not in the org chart
This person is not in any teams
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com